The Australian patent for the use of stem cell secretions for the tropical treatment of acne is value accretive for Regeneus and opens up the $3 billion per annum global market for acne-based prescription treatments. Partners are being sought to help commercialise Regeneus’ secretions technology.
The Australian patent for the use of stem cell secretions for...
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
